278 related articles for article (PubMed ID: 31941258)
1. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
[TBL] [Abstract][Full Text] [Related]
2. [Guideline for the prevention and treatment of hepatitis C (2022 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1332-1348. PubMed ID: 36891719
[TBL] [Abstract][Full Text] [Related]
3. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
Rao HY; Duan ZP; Wang GQ; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1309-1331. PubMed ID: 36891718
[TBL] [Abstract][Full Text] [Related]
5. [Interpretation of the important update of the Guideline for the prevention and treatment of hepatitis C (2022 edition)].
Rao HY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):688-691. PubMed ID: 37580249
[TBL] [Abstract][Full Text] [Related]
6. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):938-961. PubMed ID: 31941257
[TBL] [Abstract][Full Text] [Related]
7. [Chronic hepatitis C: achievement, challenge and strategy to eliminate as a public health threat].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):161-168. PubMed ID: 29804387
[TBL] [Abstract][Full Text] [Related]
8. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Omata M; Kanda T; Wei L; Yu ML; Chuang WL; Ibrahim A; Lesmana CR; Sollano J; Kumar M; Jindal A; Sharma BC; Hamid SS; Dokmeci AK; Al-Mahtab M; McCaughan GW; Wasim J; Crawford DH; Kao JH; Yokosuka O; Lau GK; Sarin SK
Hepatol Int; 2016 Sep; 10(5):681-701. PubMed ID: 27229718
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
AASLD-IDSA HCV Guidance Panel
Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on clinical antiviral treatment of chronic hepatitis B in children].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):435-448. PubMed ID: 38858193
[TBL] [Abstract][Full Text] [Related]
11. Viral hepatitis C in 2014--the beginning of the end?
Prelipcean CC; Gogălniceanu P; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
[No Abstract] [Full Text] [Related]
12. [The guideline of prevention and treatment for hepatitis C: a 2015 update].
; Wei L; ; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):906-23. PubMed ID: 26739465
[No Abstract] [Full Text] [Related]
13. [Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3].
Jung YK
Korean J Gastroenterol; 2016 Mar; 67(3):132-6. PubMed ID: 26996182
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
[TBL] [Abstract][Full Text] [Related]
15. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
16. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
Soriano V; Tefferi A
Cancer; 2018 Apr; 124(8):1647-1649. PubMed ID: 29486060
[No Abstract] [Full Text] [Related]
17. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
AASLD/IDSA HCV Guidance Panel
Hepatology; 2015 Sep; 62(3):932-54. PubMed ID: 26111063
[No Abstract] [Full Text] [Related]
18. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
19. Is hepatitis C virus eradication around the corner only 25 years after its discovery?
Ippolito G; Capobianchi MR; Lanini S; Antonelli G
Int J Antimicrob Agents; 2015 Feb; 45(2):111-2. PubMed ID: 25249016
[TBL] [Abstract][Full Text] [Related]
20. New hepatitis C therapies.
Pawlotsky JM
Semin Liver Dis; 2014 Feb; 34(1):7-8. PubMed ID: 24782253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
